Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters











Publication year range
1.
Biomolecules ; 10(3)2020 03 08.
Article in English | MEDLINE | ID: mdl-32182711

ABSTRACT

The p53 transcription factor plays a critical role in cellular responses to stress. Its activation in response to DNA damage leads to cell growth arrest, allowing for DNA repair, or directs cellular senescence or apoptosis, thereby maintaining genome integrity. Senescence is a permanent cell-cycle arrest that has a crucial role in aging, and it also represents a robust physiological antitumor response, which counteracts oncogenic insults. In addition, senescent cells can also negatively impact the surrounding tissue microenvironment and the neighboring cells by secreting pro-inflammatory cytokines, ultimately triggering tissue dysfunction and/or unfavorable outcomes. This review focuses on the characteristics of senescence and on the recent advances in the contribution of p53 to cellular senescence. Moreover, we also discuss the p53-mediated regulation of several pathophysiological microenvironments that could be associated with senescence and its development.


Subject(s)
Cell Cycle Checkpoints , Cellular Microenvironment , Cellular Senescence , DNA Damage , DNA Repair , Tumor Suppressor Protein p53/metabolism , Animals , Humans , Tumor Suppressor Protein p53/genetics
2.
Am J Physiol Endocrinol Metab ; 315(4): E676-E693, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29509432

ABSTRACT

Obesity is associated with adipose tissue inflammation that contributes to insulin resistance. Zinc finger protein 36 (Zfp36) is an mRNA-binding protein that reduces inflammation by binding to cytokine transcripts and promoting their degradation. We hypothesized that myeloid-specific deficiency of Zfp36 would lead to increased adipose tissue inflammation and reduced insulin sensitivity in diet-induced obese mice. As expected, wild-type (Control) mice became obese and diabetic on a high-fat diet, and obese mice with myeloid-specific loss of Zfp36 [knockout (KO)] demonstrated increased adipose tissue and liver cytokine mRNA expression compared with Control mice. Unexpectedly, in glucose tolerance testing and hyperinsulinemic-euglycemic clamp studies, myeloid Zfp36 KO mice demonstrated improved insulin sensitivity compared with Control mice. Obese KO and Control mice had similar macrophage infiltration of the adipose depots and similar peripheral cytokine levels, but lean and obese KO mice demonstrated increased Kupffer cell (KC; the hepatic macrophage)-expressed Mac2 compared with lean Control mice. Insulin resistance in obese Control mice was associated with enhanced Zfp36 expression in KCs. Compared with Control mice, KO mice demonstrated increased hepatic mRNA expression of a multitude of classical (M1) inflammatory cytokines/chemokines, and this M1-inflammatory hepatic milieu was associated with enhanced nuclear localization of IKKß and the p65 subunit of NF-κB. Our data confirm the important role of innate immune cells in regulating hepatic insulin sensitivity and lipid metabolism, challenge-prevailing models in which M1 inflammatory responses predict insulin resistance, and indicate that myeloid-expressed Zfp36 modulates the response to insulin in mice.


Subject(s)
Adipose Tissue/metabolism , Cytokines/genetics , Fatty Liver/genetics , Inflammation/genetics , Insulin Resistance/genetics , Obesity/genetics , Tristetraprolin/genetics , Adipose Tissue/immunology , Adipose Tissue/pathology , Animals , Cytokines/immunology , Cytokines/metabolism , Diabetes Mellitus/genetics , Diabetes Mellitus/immunology , Diabetes Mellitus/metabolism , Diet, High-Fat , Fatty Liver/immunology , Fatty Liver/metabolism , I-kappa B Kinase/immunology , I-kappa B Kinase/metabolism , Inflammation/immunology , Inflammation/metabolism , Kupffer Cells/immunology , Kupffer Cells/metabolism , Mice , Mice, Knockout , Myeloid Cells/metabolism , Obesity/immunology , Obesity/metabolism , Organ Size , RNA, Messenger/metabolism , Transcription Factor RelA/immunology , Transcription Factor RelA/metabolism , Tristetraprolin/immunology , Tristetraprolin/metabolism
3.
J Neuropathol Exp Neurol ; 74(7): 723-42, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26079448

ABSTRACT

The expression, cellular distribution, and subcellular sorting of the microtubule (MT)-nucleating γ-tubulin small complex (γTuSC) proteins, GCP2 and GCP3, were studied in human glioblastoma cell lines and in clinical tissue samples representing all histologic grades of adult diffuse astrocytic gliomas (n = 54). Quantitative real-time polymerase chain reaction revealed a significant increase in the expression of GCP2 and GCP3 transcripts in glioblastoma cells versus normal human astrocytes; these were associated with higher amounts of both γTuSC proteins. GCP2 and GCP3 were concentrated in the centrosomes in interphase glioblastoma cells, but punctate and diffuse localizations were also detected in the cytosol and nuclei/nucleoli. Nucleolar localization was fixation dependent. GCP2 and GCP3 formed complexes with γ-tubulin in the nucleoli as confirmed by reciprocal immunoprecipitation experiments and immunoelectron microscopy. GCP2 and GCP3 depletion caused accumulation of cells in G2/M and mitotic delay but did not affect nucleolar integrity. Overexpression of GCP2 antagonized the inhibitory effect of the CDK5 regulatory subunit-associated tumor suppressor protein 3 (C53) on DNA damage G2/M checkpoint activity. Tumor cell GCP2 and GCP3 immunoreactivity was significantly increased over that in normal brains in glioblastoma samples; it was also associated with microvascular proliferation. These findings suggest that γTuSC protein dysregulation in glioblastomas may be linked to altered transcriptional checkpoint activity or interaction with signaling pathways associated with a malignant phenotype.


Subject(s)
Brain Neoplasms/metabolism , Cell Nucleolus/metabolism , Gene Expression Regulation, Neoplastic/physiology , Glioblastoma/metabolism , Microtubule-Associated Proteins/metabolism , Animals , Anura , Brain Neoplasms/pathology , Brain Neoplasms/ultrastructure , Cell Cycle/physiology , Cell Line, Tumor , Chickens , DNA Damage/genetics , Female , Glioblastoma/pathology , Glioblastoma/ultrastructure , Humans , Male , Mice , Microtubule-Associated Proteins/genetics , Middle Aged , Protein Transport , Tubulin/metabolism , Tumor Suppressor Protein p53/metabolism , Young Adult , Zebrafish
4.
Arterioscler Thromb Vasc Biol ; 33(6): 1212-20, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23559629

ABSTRACT

OBJECTIVE: We studied the expression and function of an mRNA-binding protein, zinc finger protein-36 (ZFP36), in vascular endothelial cells in vivo and in vitro. We tested the hypotheses that ZFP36 regulates inflammation in vascular endothelial cells and that it functions through direct binding to target cytokine mRNAs. We also tested whether ZFP36 inhibits nuclear factor-κB-mediated transcriptional responses in vascular endothelial cells. APPROACH AND RESULTS: ZFP36 was minimally expressed in healthy aorta but was expressed in endothelial cells overlying atherosclerotic lesions in mice and humans. The protein was also expressed in macrophage foam cells of atherosclerosis. ZFP36 was expressed in human aortic endothelial cells in response to bacterial lipopolysaccharide, glucocorticoid, and forskolin, but not oxidized low-density lipoproteins or angiotensin II. Functional studies demonstrated that ZFP36 reduces the expression of inflammatory cytokines in target cells by 2 distinct mechanisms: ZFP36 inhibits nuclear factor-κB transcriptional activation and also binds to cytokine mRNAs, leading to reduced transcript stability. CONCLUSIONS: ZFP36 is expressed in vascular endothelial cells and macrophage foam cells where it inhibits the expression of proinflammatory mRNA transcripts. The anti-inflammatory effects of ZFP36 in endothelial cells occur via both transcriptional and posttranscriptional mechanisms. Our data suggest that enhancing vascular ZFP36 expression might reduce vascular inflammation.


Subject(s)
Cytokines/metabolism , Endothelial Cells/metabolism , Foam Cells/metabolism , Gene Expression Regulation , Tristetraprolin/genetics , Animals , Aorta , Atherosclerosis/genetics , Atherosclerosis/physiopathology , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cells, Cultured , Disease Models, Animal , Endothelial Cells/cytology , Foam Cells/cytology , Humans , Inflammation/genetics , Inflammation/prevention & control , Mice , Mice, Inbred C57BL , RNA, Messenger/genetics , RNA, Messenger/metabolism , Random Allocation , Reference Values , Sensitivity and Specificity , Vasculitis/genetics , Vasculitis/prevention & control
5.
J Cell Biochem ; 114(3): 728-34, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23060074

ABSTRACT

Cyclin-dependent kinase 9 (Cdk9) is a serine-threonine kinase, involved in many cellular processes. The regulatory units of Cdk9 are the T family Cyclins (T1, T2) and Cyclin K. Cyclin T2 has two forms termed Cyclin T2a and Cyclin T2b that arise by an alternative splicing of the primary transcript. Upon induction of muscle differentiation, MyoD recruits Cdk9/Cyclin T2 on muscle-specific gene promoter sequences. This complex is able to phosphorylate the C-terminal domain of RNA polymerase II, enhancing MyoD function and promoting myogenic differentiation. This work focuses on the characterization of two murine Cyclin T2 isoforms and the evaluation of the role of Cdk9/Cyclin T2 complexes during the skeletal muscle differentiation. This study demonstrated a predominant expression of isoform b in all stages of differentiation. Moreover, both isoforms of Cyclin T2 are able to activate the myogenic program but Cyclin T2b has a predominant role, in particular during the latest stages.


Subject(s)
Cell Differentiation/genetics , Cyclin T/genetics , Cyclin T/metabolism , Muscle, Skeletal/cytology , Muscle, Skeletal/metabolism , Alternative Splicing , Animals , Base Sequence , Cell Division , Cells, Cultured , Cyclin-Dependent Kinase 9/genetics , Cyclin-Dependent Kinase 9/metabolism , Gene Expression Regulation, Developmental , Mice , Muscle, Skeletal/embryology , MyoD Protein/metabolism , Myoblasts , Phosphorylation , Promoter Regions, Genetic , Protein Isoforms/genetics , RNA Polymerase II/metabolism , Sequence Analysis, DNA , Transcription, Genetic
6.
Histol Histopathol ; 27(9): 1183-94, 2012 09.
Article in English | MEDLINE | ID: mdl-22806905

ABSTRACT

We and others have previously shown that increased expression and altered compartmentalization of γ-tubulin may contribute to tumorigenesis and tumor progression (J. Cell Physiol. 2009;223:519-529; Cancer Biol. Ther. 2010;9:66-76). Here we have determined by immunohistochemistry the localization and cellular distribution of γ-tubulin in clinical tissue samples from 109 non-small cell lung cancer (NSCLC) cases. The expression and distribution of γ-tubulin protein and transcripts was also determined in the NSCLC tumor cell lines NCI-H460 (HTB-177) and NCI-H69 (HTB-119) by immunocytochemistry, quantitative immunoblotting and reverse transcription quantitative real-time PCR (RT-qPCR). Polyclonal and monoclonal anti-peptide antibodies recognizing epitopes in the C- or N-terminal domains of γ-tubulins and human gene-specific primers for γ-tubulins 1 (TUBG1) and 2 (TUBG2) were used. In non-neoplastic cells of the airway epithelium in situ, γ-tubulin exhibited predominantly apical surface and pericentriolar localizations. In contrast, markedly increased, albeit heterogeneous and variously prominent γ-tubulin immunoreactivity was detected in clinical tumor specimens and in the NCI-H460 and NCI-H69 cell lines, where tumor cells exhibited overlapping multi-punctate and diffuse patterns of localization. Co-expression of γ-tubulin and Ki-67 (MIB-1) was detected in a population of proliferating tumor cells. A statistically significant increase of γ-tubulin expression was found in Stage III compared to lesser stage tumors (p<0.001 v. Stages I/II) regardless of histological subtype or grade. By quantitative immunoblotting NCI-H460 and NCI-H69 cells expressed higher levels of γ-tubulin protein compared to small airway epithelial cells (SAEC). In both tumor cell lines increase in TUBG1 and TUBG2 transcripts was detected by RT-qPCR. Our results reveal for the first time an increased expression of γ-tubulin in lung cancer.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Non-Small-Cell Lung/metabolism , Lung Neoplasms/metabolism , Tubulin/biosynthesis , Adult , Aged , Aged, 80 and over , Carcinoma, Non-Small-Cell Lung/pathology , Female , Humans , Immunoblotting , Immunohistochemistry , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
7.
Cell Cycle ; 11(9): 1841-50, 2012 May 01.
Article in English | MEDLINE | ID: mdl-22544282

ABSTRACT

Distinct molecular pathways could be constitutively active in mouse T-Antigen positive and T-Antigen negative medulloblastoma cell lines, contributing to their phenotypic differences as well as to cellular responses, cell cycle progression, cell death and survival. The diversity of these responses may be due, at least in part, to distinct activities of Rb2/p130, CTCF and BORIS proteins in response to an altered network of signaling evoked by the T-Ag presence. Here, we provided evidence supporting a role for the T-Antigen in causing chronic endoplasmic reticulum (ER) stress and aberrant Caspase-12 expression and activation, subsequently driving to both massive cell death, and perhaps selection of cells with a higher malignant phenotype. Furthermore, we observed that the endoplasmic stress, either chronically caused by T-Ag or transiently induced by glucose deprivation, is accompanied by the formation of complexes between the retinoblastoma related protein Rb2/p130 and the chromatin insulator CCCTC-binding factor CTCF, or the CTCF-paralogue BORIS. Our study represents the first evidence supporting a role of the T-Antigen in inducing/maintaining chronic ER-stress, as well as, indicating a role of Rb2/p130, CTCF and BORIS as potential mediators of non-canonical ER-dependent death pathway in mouse medulloblastoma.


Subject(s)
Antigens, Viral, Tumor/metabolism , Cell Death , Endoplasmic Reticulum Stress , Endoplasmic Reticulum/pathology , Medulloblastoma/pathology , Animals , Apoptosis , CCCTC-Binding Factor , Caspase 12/metabolism , Chromatin Immunoprecipitation , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Endoplasmic Reticulum/metabolism , Enzyme Activation , Gene Expression Regulation, Neoplastic , Glucose/metabolism , Medulloblastoma/genetics , Medulloblastoma/metabolism , Mice , Mice, Transgenic , Repressor Proteins/genetics , Repressor Proteins/metabolism , Retinoblastoma-Like Protein p130/genetics , Retinoblastoma-Like Protein p130/metabolism , Signal Transduction , Tumor Cells, Cultured , Tumor Microenvironment
8.
Cell Cycle ; 11(6): 1202-16, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22391209

ABSTRACT

Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy. The effects of flavopiridol and of siRNA-mediated inhibition of Cdk9 and/or Cdk7 were analyzed in human glioblastoma and human prostate cancer cell lines. One finding revealed that Cdk9 and Cdk7 could substitute each other in RNA polII CTD phosphorylation in contrast to the in vitro system. Thus, a simultaneous inhibition of Cdk9 and Cdk7 might be required both for targeting malignant cells and developing a platform for microarray analysis. However, these two pathways are not redundant, as indicated by differential effects observed in cell cycle regulation following siRNA-mediated inhibition of Cdk9 and/or Cdk7 in human PC3 prostate cancer cell line. Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line. Another finding showed that flavopiridol treatment induced a substantial AKT-Ser473 phosphorylation in human glioblastoma T98G cell line in contrast to siRNA-mediated inhibition of Cdk9 and Cdk9 combined with Cdk7, whereas siRNA-mediated silencing of Cdk7 caused a minor increase in AKT-Ser473 phosphorylation. AKT-Ser473 is a hallmark of AKT pathway activation and may protect cells from apoptosis. This finding also shows that Cdk9 and Cdk7 pathways are not redundant and may have important implications in drug development and for studying the mechanism of chemoresistance in malignant cells.


Subject(s)
Cyclin-Dependent Kinase 9/metabolism , Flavonoids/pharmacology , Piperidines/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , RNA, Small Interfering/metabolism , Blotting, Western , Cell Cycle , Cell Line, Tumor , Cyclin-Dependent Kinase 9/antagonists & inhibitors , Cyclin-Dependent Kinase 9/genetics , Cyclin-Dependent Kinases/antagonists & inhibitors , Cyclin-Dependent Kinases/genetics , Cyclin-Dependent Kinases/metabolism , Dose-Response Relationship, Drug , Drug Design , Enzyme Activation , Gene Expression Regulation, Neoplastic , Gene Silencing , Glioblastoma/genetics , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Phosphorylation , Proto-Oncogene Proteins c-akt/genetics , RNA Polymerase II/genetics , RNA Polymerase II/metabolism , RNA, Small Interfering/genetics , Serine/genetics , Serine/metabolism , Signal Transduction , Time Factors , Cyclin-Dependent Kinase-Activating Kinase
9.
FASEB J ; 24(8): 2881-92, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20354138

ABSTRACT

Medulloblastoma is the most common malignant brain tumor in children, and despite improvements in the overall survival rate, it still lacks an effective treatment. Src plays an important role in cancer, and recently high Src activity was documented in medulloblastoma. In this report, we examined the effects of novel pyrazolo-[3,4-d]-pyrimidine derivative Src inhibitors in medulloblastoma. By MTS assay, we showed that the pyrimidine derivatives indicated as S7, S29, and SI163 greatly reduce the growth rate of medulloblastoma cells by inhibiting Src phosphorylation, compared with HT22 non-neoplastic nerve cells. These compounds also halt cells in the G(2)/M phase, and this effect likely occurs through the regulation of cdc2 and CDC25C phosphorylation, as shown by Western blot. Moreover, the exposure to pyrimidine derivatives induces apoptosis, assayed by the supravital propidium iodide assay, through modulation of the apoptotic proteins Bax and Bcl2, and inhibits tumor growth in vivo in a mouse model. Notably, S7, S29, and SI163 show major inhibitory effects on medulloblastoma cell growth compared with the chemotherapeutic agents cisplatin and etoposide. In conclusion, our results suggest that S7, S29, and SI163 could be novel attractive candidates for the treatment of medulloblastoma or tumors characterized by high Src activity.


Subject(s)
Cell Cycle/drug effects , Cell Proliferation/drug effects , Medulloblastoma/drug therapy , Protein Kinase Inhibitors/pharmacology , Pyrimidines/chemistry , src-Family Kinases/antagonists & inhibitors , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Humans , Medulloblastoma/pathology , Protein Kinase Inhibitors/chemistry , Pyrimidines/pharmacology , Pyrimidines/therapeutic use
10.
J Cell Biochem ; 110(1): 182-90, 2010 May.
Article in English | MEDLINE | ID: mdl-20336668

ABSTRACT

The formation and progression of mudulloblastoma (MB) is poorly understood. However, somatic inactivation of pRb/p105, in combination with a somatic or a germ-line TP53 inactivation, leads to MB in a mouse model. Presently, there is no specific evidence of pathway/s alterations for the other two members of the retinoblastoma family, pRb2/p130 and/or p107 in MB. JC virus (JCV) is a human polyomavirus. Although there is no firm evidence that this virus plays a causal role in human neoplasia, it has been clearly proven that JCV is highly oncogenic when injected into the brain of experimental animals. The mechanism of JCV-induced tumorigenesis is not entirely clear. However, several studies relate the oncogenic properties of JCV mainly to its early protein large T-antigen (T-Ag), which is able to bind and inactivate both TP53 and Rb family proteins. Here, we compared the protein expression profiles of p53, p73, pRb family proteins, and PCNA, as main regulators of cell proliferation and death, in different cell lines of mouse primitive neuroectodermal tumors (PNET), either T-Ag-positive or -negative, and in human MB cell lines. Our goal was to determine if changes in the relative expression of these regulators could trigger molecular perturbations underlying MB pathogenesis in mouse and human cells. Our results support that the presence of JCV T-Ag may interfere with the expression of pRb family proteins, specific p73 isoforms, and p53. In turn, this "perturbation" may trigger a network of signals strictly connected with survival and apoptosis.


Subject(s)
Antigens, Viral, Tumor/immunology , DNA-Binding Proteins/metabolism , JC Virus/immunology , Medulloblastoma/metabolism , Nuclear Proteins/metabolism , Retinoblastoma Protein/metabolism , Signal Transduction , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Proteins/metabolism , Animals , Cell Line, Tumor , Child, Preschool , Fibroblasts/metabolism , Gene Expression Profiling , Humans , Male , Medulloblastoma/virology , Mice , Neoplasm Proteins/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Tumor Protein p73
11.
Cell Cycle ; 9(6): 1131-42, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20237420

ABSTRACT

NSP 5a3a had been identified along with three other distinct though similar isoforms corresponding to locus HCMOGT-1 on chromosome 17p11.2. ( 1) Secondary structure analysis of the NSP isoforms revealed similarity to Spectrin and Spectrin like proteins containing coiled coil domains. ( 1) These proteins have been implicated and found to be involved in a plethora of cellular activities ranging from intracellular trafficking, cellular and subcellular integrity ( 2, 3) to being involved in protein-protein interactions with other structural proteins as well as involved in protein complex stabilization and scaffolding thus facilitating homo or hetero dimerization of protein complexes. ( 4) The NSP 5a3a isoform had been identified to be highly expressed in-vitro in particular cancer cell lines while very low to null in normal body tissues. ( 1) Subsequent investigation of this isoform revealed its novel interaction with B23 ( 5) , a known nucleolar protein involved in ribosome biogenesis, rRNA transcription, mitosis, cell growth control, and apoptosis. ( 6) We have since then, further elucidated its potential involvement in cellular processes such as ribosome biogenesis and rRNA processing by confirming and establishing NSP 5a3a's novel interaction with B23 and ribonuclear protein hnRNP-L, respectively thus possibly implicating NSP 5a3a in cellular processes such as ribosome biogenesis and rRNA transcription . Finally, an intriguing differential cooperation between these proteins has been observed in both normal and cancer breast cell models and additionally through siRNa silencing, we have found hnRNP-L as a potential novel regulator of NSP 5a3a.


Subject(s)
Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Nucleus/metabolism , Heterogeneous-Nuclear Ribonucleoprotein L/metabolism , Nuclear Proteins/metabolism , Blotting, Western , Cell Cycle Proteins , Cell Extracts , Cell Line, Tumor , Cytoskeletal Proteins , Female , Gene Silencing , Humans , Immunoprecipitation , Neoplasm Proteins/chemistry , Neoplasm Proteins/metabolism , Nucleophosmin , Peptide Mapping , Protein Binding , Protein Transport , Proteomics , RNA, Small Interfering/metabolism , Silver Staining , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Subcellular Fractions/metabolism
12.
J Cell Physiol ; 223(2): 519-29, 2010 May.
Article in English | MEDLINE | ID: mdl-20162618

ABSTRACT

In previous studies, we have shown overexpression and ectopic subcellular distribution of gamma-tubulin and betaIII-tubulin in human glioblastomas and glioblastoma cell lines (Katsetos et al., 2006, J Neuropathol Exp Neurol 65:455-467; Katsetos et al., 2007, Neurochem Res 32:1387-1398). Here we determined the expression of gamma-tubulin in surgically excised medulloblastomas (n = 20) and in the human medulloblastoma cell lines D283 Med and DAOY. In clinical tissue samples, the immunohistochemical distribution of gamma-tubulin labeling was pervasive and inversely related to neuritogenesis. Overexpression of gamma-tubulin was widespread in poorly differentiated, proliferating tumor cells but was significantly diminished in quiescent differentiating tumor cells undergoing neuritogenesis, highlighted by betaIII-tubulin immunolabeling. By quantitative real-time PCR, gamma-tubulin transcripts for TUBG1, TUBG2, and TUBB3 genes were detected in both cell lines but expression was less prominent when compared with the human glioblastoma cell lines. Immunoblotting revealed comparable amounts of gamma-tubulin and betaIII-tubulin in different phases of cell cycle; however, a larger amount of gamma-tubulin was detected in D283 Med when compared with DAOY cells. Interphase D283 Med cells exhibited predominantly diffuse cytoplasmic gamma-tubulin localization, in addition to the expected centrosome-associated distribution. Robust betaIII-tubulin immunoreactivity was detected in mitotic spindles of DAOY cells. Our data indicate that overexpression of gamma-tubulin may be linked to phenotypic dedifferentiation (anaplasia) and tumor progression in medulloblastomas and may potentially serve as a promising tumor marker.


Subject(s)
Biomarkers, Tumor/metabolism , Brain Neoplasms/metabolism , Medulloblastoma/metabolism , Tubulin/metabolism , Biomarkers, Tumor/analysis , Brain Neoplasms/genetics , Brain Neoplasms/pathology , Cell Cycle/physiology , Cell Dedifferentiation/physiology , Cell Line, Tumor , Centrosome/metabolism , Child , Child, Preschool , Cytoplasm/metabolism , Disease Progression , Female , Gene Expression Regulation, Neoplastic/physiology , Humans , Immunohistochemistry , Infant , Male , Medulloblastoma/genetics , Medulloblastoma/pathology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Retrospective Studies , Spindle Apparatus/metabolism , Tubulin/genetics
13.
J Cell Physiol ; 219(2): 334-43, 2009 May.
Article in English | MEDLINE | ID: mdl-19115234

ABSTRACT

Large research activity has raised around the mechanisms of interaction between extremely low-frequency magnetic fields (ELF-MFs) and biological systems. ELF-MFs may interfere with chemical reactions involving reactive oxygen species (ROS), thus facilitating oxidative damages in living cells. Cortical neurons are particularly susceptible to oxidative stressors and are also highly dependent on the specific factors and proteins governing neuronal development, activity and survival. The aim of the present work was to investigate the effects of exposures to two different 50 Hz sinusoidal ELF-MFs intensities (0.1 and 1 mT) in maturing rat cortical neurons' major anti-oxidative enzymatic and non-enzymatic cellular protection systems, membrane peroxidative damage, as well as growth factor, and cytokine expression pattern. Briefly, our results showed that ELF-MFs affected positively the cell viability and concomitantly reduced the levels of apoptotic death in rat neuronal primary cultures, with no significant effects on the main anti-oxidative defences. Interestingly, linear regression analysis suggested a positive correlation between reduced glutathione (GSH) and ROS levels in 1 mT MF-exposed cells. On this basis, our hypothesis is that GSH could play an important role in the antioxidant defence towards the ELF-MF-induced redox challenge. Moreover, the GSH-based cellular response was achieved together with a brain-derived neurotrophic factor over-expression as well as with the interleukin 1beta-dependent regulation of pro-survival signaling pathways after ELF-MF exposure.


Subject(s)
Cerebral Cortex/cytology , Electromagnetic Fields , Neurons/metabolism , Neurons/radiation effects , Adult , Animals , Antioxidants/metabolism , Cell Membrane/metabolism , Cells, Cultured , Cytokines/genetics , Cytokines/metabolism , Glutathione/metabolism , Humans , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Nerve Growth Factors/genetics , Nerve Growth Factors/metabolism , Neurons/cytology , Oxidation-Reduction , Oxidative Stress , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
14.
Clin Cancer Res ; 14(4): 971-6, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18281528

ABSTRACT

Medulloblastoma is the most common malignant tumor of central nervous system in children. Patients affected by medulloblastoma may be categorized as high-risk and standard-risk patients, based on the clinical criteria and histologic features of the disease. Currently, multimodality treatment, including surgery, radiotherapy, and chemotherapy is considered as the most effective strategy against these malignant cerebellar tumors of the childhood. Despite the potential poor outcomes of these lesions, the 5-year survival stands, at present, at 70% to 80% for standard-risk patients, whereas high-risk patients have a 5-year survival of 55% to 76%. Attempts to further reduce the morbidity and mortality associated with medulloblastoma have been restricted by the toxicity of conventional treatments and the infiltrative nature of the disease. Over the past decade, new discoveries in molecular biology have revealed new insights in signaling pathways regulating medulloblastoma tumor formation. Recent advances in the molecular biology of medulloblastoma indicate that the classification of these embryonal tumors, solely based on histology and clinical criteria, may not be adequate enough. Better understanding of the growth control mechanisms involved in the development and progression of medulloblastoma will allow a better classification, leading to the improvement of the existing therapies, as well as to the development of new therapeutic approaches.


Subject(s)
Cerebellar Neoplasms/metabolism , Cerebellar Neoplasms/therapy , Medulloblastoma/genetics , Medulloblastoma/metabolism , Medulloblastoma/therapy , Animals , Cerebellar Neoplasms/genetics , Child , Humans , Molecular Biology
15.
J Cell Physiol ; 212(1): 96-104, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17385710

ABSTRACT

Human polyomaviruses, which include JC virus (JCV) and BK virus (BKV), as well as the simian virus 40 (SV40), have been associated with human tumors and have been shown to be highly tumorigenic in experimental animal models. Although the mechanism by which JCV induces tumorigenesis is not entirely clear, earlier studies point to the involvement of the viral early protein T-antigen which has the ability to bind and inactivate tumor suppressors and cell cycle regulatory proteins, such as the retinoblastoma family proteins and p53. We investigated if the distribution between nucleus and cytoplasm of the transcription factors E2F4 and E2F5 is mediated by pRb2/p130 and if the presence of JCV T-antigen may impair this shuttling by sequestering pRb2/p130. The results showed that E2F4 was prevalently localized in the nucleus of both T-antigen positive and -negative R503 cells independently of the cell cycle phase. E2F5 instead was prevalently localized in the cytoplasmic fraction in G(0)/G(1), S-phase synchronized, and asynchronous R503 and R503 T-Ag positive cells. The presence of T-antigen did not influence the subcellular localization of these transcription factors E2F4 and E2F5, at least in this murine cellular model. Moreover, Small interference RNA experiments directed toward silencing the Rb2/p130 gene demonstrated that pRb2/p130 does not play a predominant role in the nuclear transportation of E2F4 and E2F5.


Subject(s)
Antigens, Viral/metabolism , E2F4 Transcription Factor/metabolism , E2F5 Transcription Factor/metabolism , JC Virus/metabolism , Retinoblastoma Protein/metabolism , Retinoblastoma/metabolism , Animals , Cell Cycle , Cells, Cultured , Gene Expression Regulation , Medulloblastoma , Mice , Transfection
16.
In Vitro Cell Dev Biol Anim ; 42(5-6): 134-42, 2006.
Article in English | MEDLINE | ID: mdl-16848632

ABSTRACT

To examine whether a neuronal cell suspension can be held in vitro for a relatively short period without compromising survival rates and functionality, we have set up an experimental protocol planning 24 h of suspension culture in a rotary wall vessel (RWV) bioreactor before plating in a conventional adherent system. Apoptosis measurement and activated caspase-8, -9, and -3 detection have demonstrated that survey of the cells was not affected. The activity of major antioxidant enzymes (AOE), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT), was significantly decreased in RWV-maintained cells. A significant decrease of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) is coupled with a level of activated nuclear factor-kappaB (NF-kappaB) protein significantly lower in RVW cells than in the control. On the contrary, the level of IL-6 expression did not change between the test and the control. A significant up-regulation of growth-associated protein-43 (GAP-43), peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta), and acyl-CoA synthetase 2 (ACS2) in RWV cells has been detected. We provide the evidence that primary neuronal cells, at an early stage of development, can be maintained in a suspension condition before adherent plating. This experimental environment does not induce detrimental effects but may have an activator role, leading cells to development and maturation in a tridimensional state.


Subject(s)
Bioreactors , Cell Culture Techniques/instrumentation , Neurons/cytology , Animals , Antioxidants/metabolism , Apoptosis , Catalase/metabolism , Coenzyme A Ligases/genetics , Coenzyme A Ligases/metabolism , GAP-43 Protein/genetics , GAP-43 Protein/metabolism , Gene Expression Regulation , Glutathione Peroxidase/metabolism , Interleukin-1/genetics , Interleukin-1/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , PPAR delta/genetics , PPAR delta/metabolism , PPAR-beta/genetics , PPAR-beta/metabolism , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
17.
In Vitro Cell Dev Biol Anim ; 40(5-6): 159-65, 2004.
Article in English | MEDLINE | ID: mdl-15479120

ABSTRACT

Although a wealth of evidence supports the hypothesis that some functions of the nervous system may be altered during exposure to microgravity, the possible changes in basic neuronal physiology are not easy to assess. Indeed, few studies have examined whether microgravity affects the development of neurons in culture. In the present study, a suspension of dissociated cortical cells from rat embryos were exposed to 24 h of simulated microgravity before plating in a normal adherent culture system. Both preexposed and control cells were used after a period of 7-10 d in vitro. The vitality and the level of reactive oxygen species of cultures previously exposed did not differ from those of normal cultures. Cellular characterization by immunostaining with a specific antibody displayed normal neuronal phenotype in control cells, whereas pretreatment in simulated microgravity revealed an increase of glial fibrillary acidic protein fluorescence in the elongated stellate glial cells. Electrophysiological recording indicated that the electrical properties of neurons preexposed were comparable with those of controls. Overall, our results indicate that a short time of simulated microgravity preexposure does not affect dramatically the ability of dissociated neural cells to develop and differentiate in an adherent culture system.


Subject(s)
Cerebral Cortex/cytology , Embryo, Mammalian/cytology , Neurons/cytology , Weightlessness Simulation , Animals , Cell Differentiation/physiology , Cell Survival/physiology , Cerebral Cortex/metabolism , Electrophysiology/methods , Embryo, Mammalian/metabolism , Female , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry/methods , Microtubule-Associated Proteins/metabolism , Neurons/metabolism , Pregnancy , Rats , Reactive Oxygen Species/metabolism
18.
Brain Res ; 1006(2): 157-67, 2004 May 01.
Article in English | MEDLINE | ID: mdl-15051519

ABSTRACT

Methylglyoxal (MG) is one of the most powerful glycating agents of proteins and other important cellular components and has been shown to be toxic to cultured cells. Under hyperglycaemic conditions, an increase in the concentration of MG has been observed in human body fluids and tissues that seems to be responsible for diabetic complications. Recent data suggest that diabetes may cause impairment of cognitive processes, according to a mechanism involving both oxidative stress and advanced glycation end product (AGE) formation. In this work, we explored the molecular mechanism underlying MG toxicity in neural cells, by investigating the effect of MG on both the interleukin-1beta (IL-1beta), as the major inducer of the acute phase response, and the nervous growth factor (NGF) expression. Experiments were performed on cultured neural cells from rat hippocampus, being this brain region mostly involved in cognitive processes and, therefore, possible target of diabetes-mediated impairment of cognitive abilities. Results show that MG treatment causes in hippocampal neural cells extensive, oxidative stress-mediated cell death, in consequence of a strong catalase enzymatic activity and protein inhibition. MG also causes a very significant increase in both transcript and protein expression of the NGF as well as of the pro-inflammatory cytokine IL-1beta. MG co-treatment with the antioxidant N-acetylcysteine (NAC) completely abrogates the observed effects. Taken together, these data demonstrate that hippocampal neurons are strongly susceptible to MG-mediated oxidative stress.


Subject(s)
Hippocampus/cytology , Interleukin-1/metabolism , Nerve Growth Factor/metabolism , Neurons/drug effects , Oxidative Stress/drug effects , Pyruvaldehyde/toxicity , Acetylcysteine/pharmacology , Animals , Blotting, Western/methods , Cell Death/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Interactions , Embryo, Mammalian , Enzyme-Linked Immunosorbent Assay/methods , Fluoresceins , Free Radical Scavengers/pharmacology , Gene Expression Regulation/drug effects , Oxidative Stress/physiology , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Superoxide Dismutase/metabolism , Time Factors , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL